UPM Biomedicals is the world’s first to produce high quality wood-based nanofibrillar cellulose (NFC) for life science and clinical applications in accordance with ISO 13485 medical device quality management system.
GrowDex® is a ready-to-use hydrogel for 3D cell culture without temperature control, mimicking the extracellular matrix supporting cell growth and differentiation. NFC is used in multiple applications from HTS drug screening, 3D cell culture, personalized medicine and 3D bioprinting to tissue engineering.
We are part of UPM Corporation that provides renewable solutions for various end uses. We employ 17,200 people worldwide and our annual sales are approximately EUR 11.7 billion.